Rockville, MD - The US Food and Drug Administration announced Thursday it will be adding warnings alerting of the potential risks associated with v aldecoxib (Bextra, Pfizer). The new warning labels ...

Valdecoxib is a non-steroidal anti-inflammatory drug (NSAID), prescribed for osteoarthritis, rheumatoid arthritis, and painful menstruation and menstrual symptoms. It works by reducing substances in ...

Details concerning the Valdecoxib combination medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and ...

Rofecoxib (Vioxx) was recently withdrawn from the market because of an increased risk of myocardial infarction and stroke. There is a similar public health concern about another coxib, valdecoxib ...

Rofecoxib and valdecoxib have been withdrawn from the market because they increase the risk of cardiovascular events. To determine whether these drugs and other types of selective cyclooxygenase 2 ...

Despite the reported beneficial effects after noncardiac surgical procedures, the safety of selective cyclo-oxygenase 2 (COX2) inhibitors has been questioned. Studies have shown that their use after ...

NEW DELHI: Arthritis drugs Rofecoxib and Valdecoxib, both of which are globally banned, are openly available at many chemist shops across the Capital. NEW DELHI: Arthritis drugs Rofecoxib and ...

Valdecoxib is not approved for use in the treatment of postoperative pain of any type. Valdecoxib is a cyclo-oxygenase-2 selective nonsteroidal anti-inflammatory drug (NSAID) that is indicated in the ...